Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-22T18:53:16.506Z Has data issue: false hasContentIssue false
  • English
  • Français

A qualitative study exploring visible components of organizational culture: what influences the use of psychotropic medicines in nursing homes?

Published online by Cambridge University Press:  18 May 2016

Mouna J. Sawan ,
Yun-Hee Jeon ,
Romano J. Fois  and
Timothy F Chen
Mouna J. Sawan*
Affiliation:
Faculty of Pharmacy, The University of Sydney, Camperdown, NSW, Australia, N507, Pharmacy and Bank Building (A15), The University of Sydney, NSW 2006, Australia
Yun-Hee Jeon
Affiliation:
Faculty of Nursing and Midwifery, The University of Sydney, Camperdown, NSW, Australia, 88 Mallett Street – Building M02, The University of Sydney, NSW 2006, Australia
Romano J. Fois
Affiliation:
Faculty of Pharmacy, The University of Sydney, Camperdown, NSW, Australia, N507, Pharmacy and Bank Building (A15), The University of Sydney, NSW 2006, Australia
Timothy F Chen
Affiliation:
Faculty of Pharmacy, The University of Sydney, Camperdown, NSW, Australia, N507, Pharmacy and Bank Building (A15), The University of Sydney, NSW 2006, Australia
*
Correspondence should be addressed to: Mouna J. Sawan, Faculty of Pharmacy, The University of Sydney, Camperdown, NSW N507, Australia, Pharmacy and Bank Building (A15), The University of Sydney NSW 2006, Australia. Phone: +61-2-9351-7812; Fax: +61-2-9351-4391 | M +61 405484066. Email: [email protected].
Get access

Abstract

Background:

The influence of organizational culture on how psychotropic medicines are used in nursing homes has not been extensively studied. Schein's theory provides a framework for examining organizational culture which begins with the exploration of visible components of an organization such as behaviors, structures, and processes. This study aimed to identify key visible components related to the use of psychotropic medicines in nursing homes.

Methods:

A qualitative study was conducted in eight nursing homes in Sydney, Australia. Purposive sampling was used to conduct semi-structured interviews with 40 participants representing a broad range of health disciplines. Thematic analysis was used to derive concepts.

Results:

Three visible components were related to psychotropic medicine use. These were drugs and therapeutics committee meetings, pharmacist led medication management reviews and formal and informal meetings with residents and their families. We found that only a few nursing homes utilized drugs and therapeutics committee meetings to address the overuse of psychotropic medicines. Pharmacist led medication management reviews provided a lever to minimize inappropriate psychotropic prescribing for a number of nursing homes; however, in others it was used as a box-ticking exercise. We also found that some nursing homes used meetings with residents and their families to review the use of psychotropic medicines.

Conclusion:

This study was the first to illustrate that visible components of organizational culture do influence the use of psychotropic medicines and explains in detail what of the culture needs to be addressed to reduce inappropriate psychotropic prescribing.

Keywords

long-term careorganizational culturenursing homespatient safetyqualitativepsychotropic medicationsantipsychotics
Type
Research Article
Information
International Psychogeriatrics , Volume 28 , Issue 10 , October 2016 , pp. 1725 - 1735
Copyright
Copyright © International Psychogeriatric Association 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

AIHW (2012). Residential aged care in Australia 2010–11: a statistical overview. Aged care statistics series Canberra: Australian Institute of Health and Welfare.Google Scholar
APAC (2002). Guidelines for medication management in residential aged care facilities. 3rd edn. Canberra: Commonwealth Department of Health and Ageing.Google Scholar
Berlowitz, D. R. et al. (2003). Quality improvement implementation in the nursing home. Health Services Research, 38, 650–683.CrossRefGoogle ScholarPubMed
Briesacher, B. A. et al. (2005). The quality of antipsychotic drug prescribing in nursing homes. Archives of Internal Medicine, 165, 1280–1285.CrossRefGoogle ScholarPubMed
Castle, N. G., Hanlon, J. T. and Handler, S. M. (2009). Results of a longitudinal analysis of national data to examine relationships between organizational and market characteristics and changes in antipsychotic prescribing in US nursing homes from 1996 through 2006. American Journal of Geriatric Pharmacotherapy, 7, 143–150.CrossRefGoogle ScholarPubMed
Cheek, J., Gilbert, A., Ballantyne, A. and Penhall, R. (2004). Factors influencing the implementation of quality use of medicines in residential aged care. Drugs & Aging, 21, 813–824.CrossRefGoogle ScholarPubMed
Chen, Y., Briesacher, B. A., Field, T. S., Tjia, J., Lau, D. T. and Gurwitz, J. H. (2010). Unexplained variation across US nursing homes in antipsychotic prescribing rates. Archives of Internal Medicine, 170, 89–95.CrossRefGoogle ScholarPubMed
Cody, M., Beck, C. and Svarstad, B. L. (2002). Challenges to the use of nonpharmacologic interventions in nursing homes. Psychiatric Services, 53, 1402–1406.CrossRefGoogle Scholar
de Almeida Neto, A. C. and Chen, T. F. (2008). When pharmacotherapeutic recommendations may lead to the reverse effect on physician decision-making. Pharmacy World & Science, 30, 3–8.CrossRefGoogle Scholar
Foley, K. L., Sudha, S., Sloane, P. D. and Gold, D. T. (2003). Staff perceptions of successful management of severe behavioral problems in dementia special care units. Dementia, 2, 105–124.CrossRefGoogle Scholar
Hartikainen, S., Lönnroos, E. and Louhivuori, K. (2007). Medication as a risk factor for falls: critical systematic review. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 62, 1172–1181.CrossRefGoogle ScholarPubMed
Hughes, C. M. and Lapane, K. L. (2005). Administrative initiatives for reducing inappropriate prescribing of psychotropic drugs in nursing homes: how successful have they been?. Drugs & Aging, 22, 339–351.CrossRefGoogle Scholar
Hughes, C. M., Lapane, K., Watson, M. C. and Davies, H. T. O. (2007). Does organisational culture influence prescribing in care homes for older people? A new direction for research. Drugs & Aging, 24, 81–93.CrossRefGoogle ScholarPubMed
Hughes, C. M., Roughead, E. and Kerse, N. (2008). Improving use of medicines for older people in long-term care: contrasting the policy approach of four countries. Healthc Policy, 3, e154–167.Google ScholarPubMed
Hughes, C. M. et al. (2012). “The way we do things around here”: an international comparison of treatment culture in nursing homes. Journal of the American Medical Directors Association, 13, 360–367.CrossRefGoogle ScholarPubMed
Huybrechts, K. F. et al. (2012a). Comparative safety of antipsychotic medications in nursing home residents. Journal of the American Geriatrics Society, 60, 420–429.CrossRefGoogle ScholarPubMed
Huybrechts, K. F. et al. (2012b). Variation in antipsychotic treatment choice across US nursing homes. Journal of Clinical Psychopharmacology, 32, 11–17.CrossRefGoogle ScholarPubMed
Kim, H. and Whall, A. L. (2006). Factors associated with psychotropic drug usage among nursing home residents with dementia. Nursing Research, 55, 252–258.CrossRefGoogle ScholarPubMed
Kjos, B. O., Botten, G., Gjevjon, E. R. and Romoren, T. I. (2010). Quality work in long-term care: the role of first-line leaders. International Journal for Quality in Health Care, 22, 351–357.CrossRefGoogle ScholarPubMed
Légaré, F., Ratté, S., Gravel, K. and Graham, I. D. (2008). Barriers and facilitators to implementing shared decision-making in clinical practice: update of a systematic review of health professionals’ perceptions. Patient Education and Counseling, 73, 526–535.CrossRefGoogle ScholarPubMed
Lopez, R. P., Amella, E. J., Strumpf, N. E., Teno, J. M. and Mitchell, S. L. (2010). The influence of nursing home culture on the use of feeding tubes. Archives of Internal Medicine, 170, 83–88.CrossRefGoogle ScholarPubMed
Martin, J. (2002). Organizational Culture: Mapping the Terrain/by Joanne Martin. Thousand Oaks: Sage Publications.CrossRefGoogle Scholar
Nishtala, P. S., McLachlan, A. J., Bell, J. S. and Chen, T. F. (2011). A retrospective study of drug-related problems in Australian aged care homes: medication reviews involving pharmacists and general practitioners. Journal of Evaluation in Clinical Practice, 17, 97–103.CrossRefGoogle ScholarPubMed
Patton, M. Q. (2002). Qualitative Research and Evaluation Methods. Thousand Oaks, CA: Sage Publications.Google Scholar
Peri, K. et al. (2015). Is psychotropic medication use related to organisational and treatment culture in residential care. Journal of Health Organization and Management, 29, 1065–1079.CrossRefGoogle ScholarPubMed
Rattinger, G. B. et al. (2013). Pharmacotherapeutic management of dementia across settings of care. Journal of the American Geriatrics Society, 61, 723–733.CrossRefGoogle ScholarPubMed
Rochon, P. A. et al. (2007). Variation in nursing home antipsychotic prescribing rates. Archives of Internal Medicine, 167, 676–683.CrossRefGoogle ScholarPubMed
Schein, E. H. (1984). Coming to a new awareness of organizational culture. Sloan Management Review, 25, 3–16.Google Scholar
Schein, E. H. (2000). Sense and nonsense about culture and climate. In Ashkanasy, C. P. M. W. N. M. & Peterson, M. F. (Ed.), Handbook of Organizational Culture & Climate (pp. pp. xxiii–xxx): Thousand Oaks, CA: Sage.Google Scholar
Schein, E. H. (2010). Organizational Culture and Leadership. San Francisco: Jossey-Bass.Google Scholar
Schneider, L. S., Dagerman, K. and Insel, P. S. (2006). Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. The American Journal of Geriatric Psychiatry, 14, 191–210.CrossRefGoogle ScholarPubMed
Scott-Cawiezell, J. et al. (2005). Linking nursing home working conditions to organizational performance. Health Care Management Review, 30, 372–380.CrossRefGoogle ScholarPubMed
Simoni-Wastila, L. et al. (2014). Quality of psychopharmacological medication use in nursing home residents. Research in Social & Administrative Pharmacy, 10, 494–507.CrossRefGoogle ScholarPubMed
Snowdon, J., Galanos, D. and Vaswani, D. (2011). Patterns of psychotropic medication use in nursing homes: surveys in Sydney, allowing comparisons over time and between countries. International Psychogeriatrics, 23, 1520–1525.CrossRefGoogle ScholarPubMed
Stein-Parbury, J., Chenoweth, L., Jeon, Y. H., Brodaty, H., Haas, M. and Norman, R. (2012). Implementing person-centered care in residential dementia care. Clinical Gerontologist, 35, 404–424.CrossRefGoogle Scholar
Svarstad, B. L., Mount, J. K. and Bigelow, W. (2001). Variations in the treatment culture of nursing homes and responses to regulations to reduce drug use. Psychiatric Services, 52, 666–672.CrossRefGoogle ScholarPubMed
Tjia, J., Gurwitz, J. H. and Briesacher, B. A. (2012). Challenge of changing nursing home prescribing culture. American Journal of Geriatric Pharmacotherapy, 10, 37–46.CrossRefGoogle ScholarPubMed
van Beek, A. P. A. and Gerritsen, D. L. (2010). The relationship between organizational culture of nursing staff and quality of care for residents with dementia: questionnaire surveys and systematic observations in nursing homes. International Journal of Nursing Studies, 47, 1274–1282.CrossRefGoogle ScholarPubMed
Zermansky, A. G. et al. (2006). Clinical medication review by a pharmacist of elderly people living in care homes–randomised controlled trial. Age & Ageing, 35, 586–591.CrossRefGoogle ScholarPubMed
Zuidema, S. U., de Jonghe, J. F., Verhey, F. R. and Koopmans, R. T. (2011). Psychotropic drug prescription in nursing home patients with dementia: influence of environmental correlates and staff distress on physicians' prescription behavior. International Psychogeriatrics, 23, 1632–1639.CrossRefGoogle ScholarPubMed